HSIC Gears Up for Q4 Earnings: Here's What You Need to Know
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein , arguing the dental and medical distributor needs to start searching for a new CEO, cut costs and optimize capital allocation, three sources familiar with the matter said.
HSIC Stock Might Rise Following the Acquisition of Acentus
Henry Schein completes the acquisition of Acentus, which expands the former's Home Solution business.
Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes
Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC owing to the performance of its dental business.
Here's Why Henry Schein (HSIC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits
Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.
HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday.
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits
Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.
